On February 11, 2019, Brian M. Posner gave notice to Cellectar Biosciences, Inc. (the “Company”) of his resignation as Chief Financial Officer, effective March 8, 2019. The Company has initiated a search to identify and recruit a new candidate for the role of Chief Financial Officer. In connection with his resignation, Mr. Posner acknowledged that […]